-
Production of chicory root fibers with extended shelf life in Pemuco, Chile
BENEO has extended a production line at its plant in Pemuco (Chile) that enables processing capabilities for its liquid chicory root fiber Orafti® Oligofructose LL with a significantly expanded shelf life of one year. More on this topic
-
Experts Gather at the 14th European Nutrition Conference FENS
There is growing evidence demonstrating the important role nutrition plays in modulating the interaction between gut and brain. Read here insights into recent study results presented during an exclusive scientific symposium. Want to read more?
-
World Diabetes Day, 14th November 2023
Getting older is a major risk for developing type 2 diabetes but nutrition can help to delay or prevent this disease. Here, especially a low glycaemic diet is key. Some of BENEO’s functional ingredients help to lower the blood glucose response and the insulin response. Let’s start
-
Everything you need to know about Prebiotics and the gut microbiome
In her interview with Today’s Dietitian Dr. Raylene Reimer, University of Calgary, candidly shares her experience with mind-blowing research on prebiotics and chronic disease. Read the full interview
-
Promising Market Potential for Prebiotics in Southeast Asia
With a high proportion of health-conscious consumers who are aware of the importance of digestive health to overall wellbeing, Thailand and Indonesia hold strong opportunities for food and drink products containing prebiotic ingredients. BENEO will be participating in this year’s Food Ingredients Asia in Bangkok. Let’s continue reading
-
Chicory root fibres selectively increase bifidobacteria
A recently published scientific study demonstrates that prebiotic chicory root fibres support the selective growth of Bifidobacteria in the human gut, no matter which food application and food matrix they are used in. More on this topic
-
Low glycaemic properties of Isomaltulose in dogs
A new series of in-vitro and in-vivo studies demonstrates that isomaltulose is a suitable low glycaemic ingredient for use in dog food, triggering a lower blood glucose rise after consumption, compared to other carbohydrates. Click here for more
-
BENEO sells stake in Grillido
BENEO and Grillido have agreed to go their separate ways.
-
IFT 2023: BENEO Announces Extension of its Fiber Portfolio with Barley Beta-Glucans
BENEO launches Orafti® β-Fit, a functional wholemeal barley flour. The clean label ingredient contains 20 percent beta-glucans and helps lower cholesterol and blood sugar levels, among other things. Discover more
-
Niels E. Hower appointed new Member of the Executive Board of Directors at BENEO
In his role, Hower will be responsible for BENEO’s portfolio of plant-based proteins, including Meatless, a specialised company for plant-based texturising solutions, as well as faba bean ingredients and textured wheat protein. Continue reading
-
BENEO invests six million Euro in starch drying capacity
BENEO is investing six million Euro in new drying capacity at its Wijgmaal factory (Belgium) to keep pace with growing demand for its specialty rice starch ingredients. Interested in more
-
BENEO Presents its New Toolbox for Vegetal Proteins in Pet Food
As demand for plant-based pet food gathers pace, BENEO presents its toolbox of high quality and non-GMO vegetal proteins, including rice protein, vital wheat gluten and faba bean protein concentrate. Interested?
-
BENEO increases its ingredient solutions for sugar reduction
The expansion of the portfolio with the launch of Beneo-scL85, a short-chain fructooligosaccharide (scFOS) offers customers greater versatility for sugar replacement and enrichment of foods with dietary fibre.
-
Consumer survey reveals demand for scientifically proven prebiotics
According to the survey conducted by FMCG Gurus, product efficacy and proven claims are the most important consumer purchase motivators when it comes to buying functional foods with prebiotics. Learn more
-
galenIQ™ proves suitable for powder feeding in manufacturing
A recently published comparative scientific study demonstrates that BENEO’s agglomerated pharmaceutical excipient galenIQTM is suitable for continuous manufacturing of tablets. Click here
